Novo Nordisk Chief Executive Officer Mike Doustdar talks about the company's outlook as it faces headwinds on its main obesity and diabetes drugs and its shares plunged. Doustdar tells Bloomberg Television he is "confident" that "the volume build up will happen." He also talks about job cuts and says "we don't have any plans of mass layoffs." -------- More on Bloomberg Television and Markets Like this video? Subscribe and turn on notifications so you don't miss any videos from Bloomberg Markets & Finance: h ...

The company will offer its asthma and diabetes drugs at an up to 70% discount in the U.S.https://t.co/K5SwTyoKuC ...